Type VII collagen is required for Ras-driven human epidermal tumorigenesis

S Ortiz-Urda, J Garcia, CL Green, L Chen, Q Lin… - Science, 2005 - science.org
S Ortiz-Urda, J Garcia, CL Green, L Chen, Q Lin, DP Veitch, LY Sakai, H Lee…
Science, 2005science.org
Type VII collagen defects cause recessive dystrophic epidermolysis bullosa (RDEB), a
blistering skin disorder often accompanied by epidermal cancers. To study the role of
collagen VII in these cancers, we examined Ras-driven tumorigenesis in RDEB
keratinocytes. Cells devoid of collagen VII did not form tumors in mice, whereas those
retaining a specific collagen VII fragment (the amino-terminal noncollagenous domain NC1)
were tumorigenic. Forced NC1 expression restored tumorigenicity to collagen VII–null …
Type VII collagen defects cause recessive dystrophic epidermolysis bullosa (RDEB), a blistering skin disorder often accompanied by epidermal cancers. To study the role of collagen VII in these cancers, we examined Ras-driven tumorigenesis in RDEB keratinocytes. Cells devoid of collagen VII did not form tumors in mice, whereas those retaining a specific collagen VII fragment (the amino-terminal noncollagenous domain NC1) were tumorigenic. Forced NC1 expression restored tumorigenicity to collagen VII–null epidermis in a non–cell-autonomous fashion. Fibronectin-like sequences within NC1 (FNC1) promoted tumor cell invasion in a laminin 5–dependent manner and were required for tumorigenesis. Tumor-stroma interactions mediated by collagen VII thus promote neoplasia, and retention of NC1 sequences in a subset of RDEB patients may contribute to their increased susceptibility to squamous cell carcinoma.
AAAS